Carol Prives
Carol Prives | |
|---|---|
| Education | BSc McGill University, Canada
PhD McGill University, Canada Honorary Doctor of Sciences McGill University, Canada |
| Alma mater | |
| Known for | The characterization of p53, an important tumour suppressor protein frequently mutated in cancer. |
| Awards | NIH MERIT Award (1996)
Rosalind E. Franklin Award for Women in Science, National Cancer Institute (2009) Paul Janssen Prize in Biotechnology and Medicine (2010) AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship (2011) |
| Scientific career | |
| Institutions | |
 | This article is actively undergoing a major edit for a little while. To help avoid edit conflicts, please do not edit this page while this message is displayed. This page was last edited at 14:51, 16 August 2020 (UTC) (4 years ago) – this estimate is cached, . Please remove this template if this page hasn't been edited for a significant time. If you are the editor who added this template, please be sure to remove it or replace it with {{Under construction}} between editing sessions. |
Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University.[1] She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.
Education
Prives was educated in Canada, received her BSc and PhD[2] in 1966[3] from McGill University, undertaking research in the lab of Juda Hirsch Quastel.[4] She pursued postdoctoral fellowships at Albert Einstein College of Medicine and the Weizmann Institute under the mentorship of Professor Michel Revel. after which she became a faculty member at the Weizmann Institute.[1] She received an honorary Doctor of Sciences degree from McGill University, her alma mater, on 29 May 2014 for her contributions to the understanding of p53.[5]
Research and career
In 1995, she was appointed as the Da Costa Professor of Biology at Columbia University.[3] She was the chair of the Department of Biological Sciences from 2000 to 2004.[6]
Her early interest in the SV40 DNA tumour virus as a model for eukaryotic gene expression and oncogenic transformation led her to the study of p53.[7] Since the late 1980s, her lab has focused on the p53 tumour suppressor gene, one of the most frequently mutated in human cancers.
Prives has served as chair of the Experimental Virology and the Cell and Molecular Pathology study sections of the National Institutes of Health. She has been a member of the Scientific Advisory Boards of the Dana–Farber Cancer Institute, the Memorial Sloan Kettering Cancer Center, the Massachusetts General Cancer Center, the National Cancer Institute,[1] and the Weizmann Institute.[6] She was a member of the board of directors of the American Association for Cancer Research from 2004 to 2007.
She is a member of the editorial boards of Cell,[8] Oncogene[9] and the Proceedings of the National Academy of Sciences.[10]
Awards
- 1996 NIH MERIT Award
- 2000 Elected Fellow, American Academy of Arts and Sciences
- 2001 Elected Fellow, American Academy of Microbiology
- 2005 Elected Member, Institute of Medicine
- 2008 Elected Member, National Academy of Sciences[11]
- 2009 Rosalind E. Franklin Award for Women in Science[12], National Cancer Institute
- 2010 Paul Janssen Prize in Biotechnology and Medicine, Center for Advanced Biotechnology and Medicine
- 2011 AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship[3]
- 2015 Elected Fellow, AACR Academy[3]
- 2020 Elected Fellow, The Royal Society[13]
References
- ^ a b c "Carol L. Prives, PhD - AACR International". www.aacrcanada.ca.
- ^ Prives, Carole. "The biosynthesis of nucleotides and nucleic acis in Ehrlich ascites cells and the effect of colchicine thereon". escholarship.mcgill.ca. C. (Supervisor) Sung. Retrieved 2020-08-16.
- ^ a b c d "Carol L. Prives, PhD".
- ^ "Carol L. Prives Ph.D.: Executive Profile & Biography - Bloomberg". www.bloomberg.com.
- ^ Phone: 514 398-6751, Contact Information Contact: Julie Fortier Organization: Media Relations Office Email: julie c fortiermcgill ca Office. "14 individuals to receive honorary degree from McGill". Newsroom. Retrieved 2020-08-16.
{{cite web}}:|first=has generic name (help)CS1 maint: numeric names: authors list (link) - ^ a b "Prof. Carol Prives | International Board 2018". www.weizmann.ac.il. Retrieved 3 May 2019.
- ^ "Carol Prives". www.nasonline.org. Retrieved 2020-08-16.
- ^ https://www.cell.com/cell/editorial-board
- ^ "Editorial Board - Oncogene". www.nature.com.
- ^ "PNAS Member Editor Details". nrc88.nas.edu. Retrieved 3 May 2019.
- ^ http://www.nasonline.org, National Academy of Sciences -. "Carol Prives". www.nasonline.org.
{{cite web}}: External link in|last= - ^ "Past Winners of the NCI Rosalind E. Franklin Award - National Cancer Institute". dceg.cancer.gov. 2017-02-06. Retrieved 2020-08-16.
- ^ "Carol Prives FRS, Royal Society".
- Living people
- Canadian scientists
- Fellows of the AACR Academy
- Columbia University faculty
- McGill University alumni
- Canadian women scientists
- Canadian biologists
- 20th-century Canadian scientists
- 21st-century Canadian scientists
- Albert Einstein College of Medicine alumni
- 20th-century American scientists
- 21st-century American scientists
- American women scientists
- 21st-century American biologists
- Scientists from New York City